Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant

INTRODUCTION: Disorders of glucose metabolism are a serious acromegaly comorbidity and may be differently impacted by medical treatments of acromegaly. In this retrospective longitudinal multicenter study, we investigated the outcome of glucose metabolism and its predictors in patients treated with...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Endocrine
Главные авторы: Chiloiro, Sabrina, Giampietro, Antonella, Visconti, Felicia, Rossi, Laura, Donfrancesco, Federico, Fleseriu, Cara M., Mirra, Federica, Pontecorvi, Alfredo, Giustina, Andrea, Fleseriu, Maria, De Marinis, Laura, Bianchi, Antonio
Формат: Artigo
Язык:Inglês
Опубликовано: Springer US 2021
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8325668/
https://ncbi.nlm.nih.gov/pubmed/33907985
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12020-021-02711-3
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы